Nos publications
Mise à jour novembre 2023
Pagination
- Page précédente
- Page 39
- Page suivante
Title | Authors | Year | Journal | Link to Article | Intended Audience Trier par ordre décroissant | Purpose |
---|---|---|---|---|---|---|
Management of iron deficiency | Ning S, Zeller MP | 2019 | Hematology Am Soc Hematol Educ Program | View Management of iron deficiency | Health care providers | Clinical research |
Réduction des agents pathogènes dans les produits de fractionnement | Bigham M | 2019 | Guide de la pratique transfusionnelle | View Réduction des agents pathogènes dans les produits de fractionnement | Health care providers | Benchmarking and standard setting |
Combination of two complementary automated rapid assays for diagnosis of heparin-induced thrombocytopenia (HIT) | Warkentin TE, Sheppard JI, Smith JW, Li N, Moore JC, Arnold DM, Nazy I | 2020 | J Thromb Haemost | View Combination of two complementary automated rapid assays for diagnosis of heparin-induced thrombocytopenia (HIT) | Health care providers | Clinical research |
Guide des pratiques exemplaires pour la gestion des réserves de sang | Clarke G, Romans R | 2020 | Blood.ca website | View Guide des pratiques exemplaires pour la gestion des réserves de sang | Health care providers | Benchmarking and standard setting |
A prospective multi-faceted interventional study of blood bank technologist screening of red blood cell transfusion orders: The START study | Kron AT, Collins A, Cserti-Gazdewich C, Pendergrast J, Webert K, Lieberman L, Zeller MP, Harding SR, Nahirniak S, Prokopchuk-Gauk O, Lin Y, Mendez B, Armali C, Lee C, Watson D, Arnott D, Xun F, Blain H, Panchuk H, Hughes H, Chorneyko K, Angers M, Pilutti N, Lett R, Dowsley S, Ruijs T, Cupido T, Kichinko T, Thompson T, Afshar-Ghotli Z, Callum J, University of Toronto Quality in Utilization, Education and Safety in Transfusion (QUEST) Research Program | 2021 | Transfusion | View A prospective multi-faceted interventional study of blood bank technologist screening of red blood cell transfusion orders: The START study | Health care providers | Clinical research |
Massive Hemorrhage Protocol: Quality Metrics Portal Pilot | Thompson T, Callum J | 2022 | Ontario Regional Blood Coordinating Network February 2022 Newsletter | View Massive Hemorrhage Protocol: Quality Metrics Portal Pilot | Health care providers | Clinical research |
International Forum on the Management of Major Haemorrhage: Responses | Green L, Stanworth S, McQuilten Z, Lin V, Tucker H, Jackson B, Badawi M, Hindawi S, Chaurasia R, Patidar G, Pandey HC, Fasola F, Miyata S, Matsumoto M, Matsushita T, Rahimi-Levene N, Peer V, Pavenski K, Callum J, Thompson T, Murphy M, Staves J, Maegele M, Abeyakoon C, Rushford K, Wood E, Nuñez MA, Mellado S, Saa E, Triyono T, Pratomo B, Apelseth TO, Dunbar N | 2022 | Vox Sang | View International Forum on the Management of Major Haemorrhage: Responses | Health care providers | Benchmarking and standard setting |
From MPOX to the next epidemic: Words matter when talking about equity-deserving groups | Butler-Foster T, Khandelwal A, Montemayor C, Miller YM, Yan MTS, Holmberg JA, Ipe TS, Accooe P, Cancelas JA | 2023 | Transfusion | View From MPOX to the next epidemic: Words matter when talking about equity-deserving groups | Health care providers | Ethical, legal & social implications research |
Plasma transfusion practices: A multicentre electronic audit | Khandelwal A, Minuk L, Liu Y, Arnold DM, Heddle NM, Barty R, Hsia C, Solh Z, Shehata N, Thompson T, Tinmouth A, Perelman I, Skeate R, Kron AT, Callum J | 2022 | Vox Sang | View Plasma transfusion practices: A multicentre electronic audit | Health care providers | Clinical research |
Chapter 17. Hemostatic disorders and hereditary angioedema | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Clinical Guide to Transfusion | View Chapter 17. Hemostatic disorders and hereditary angioedema | Health care providers | Benchmarking and standard setting |
Approach to the diagnosis and management of drug-induced immune thrombocytopenia | Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, Kelton JG | 2013 | Transfus Med Rev | View Approach to the diagnosis and management of drug-induced immune thrombocytopenia | Health care providers | Clinical research |
Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia | Raschke RA, Gallo T, Curry SC, Whiting T, Padilla-Jones A, Warkentin TE, Puri A | 2017 | J Thromb Haemost | View Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia | Health care providers | Clinical research |
Donor deferral policies for men who have sex with men: past, present and future | Goldman M, Shih AW, O'Brien SF, Devine D | 2018 | Vox Sang | View Donor deferral policies for men who have sex with men: past, present and future | Health care providers | MSM research |
Heparin-induced thrombocytopenia | Greinacher A, Warkentin T | 2017 | Practical Transfusion Medicine, 5th Edition | View Heparin-induced thrombocytopenia | Health care providers | Clinical research |
IV immunoglobulin for autoimmune heparin-induced thrombocytopenia | Ning S, Warkentin TE | 2017 | Chest | View IV immunoglobulin for autoimmune heparin-induced thrombocytopenia | Health care providers | Clinical research |
Massive hemorrhage and emergency transfusion | Trudeau J | 2017 | Clinical Guide to Transfusion | View Massive hemorrhage and emergency transfusion | Health care providers | Benchmarking and standard setting |
Nonheparin anticoagulants for heparin-induced thrombocytopenia | Kelton JG, Arnold DM, Bates SM | 2013 | N Engl J Med | View Nonheparin anticoagulants for heparin-induced thrombocytopenia | Health care providers | Clinical research |
Pre-operative autologous donation | Pambrun C | 2017 | Clinical Guide to Transfusion | View Pre-operative autologous donation | Health care providers | Benchmarking and standard setting |
Splenectomy for immune thrombocytopenia: down but not out | Chaturvedi S, Arnold DM, McCrae KR | 2018 | Blood | View Splenectomy for immune thrombocytopenia: down but not out | Health care providers | Clinical research |
Transfusion Patterns in All Patients Admitted to the Intensive Care Unit and in Those Who Die in Hospital: A Descriptive Analysis | Shehata N, Forster AJ, Lawrence N, Ducharme R, Fergusson DA, Chassé M, Rothwell DM, Hébert PC, Tinmouth AT, Wilson K | 2015 | PLoS One | View Transfusion Patterns in All Patients Admitted to the Intensive Care Unit and in Those Who Die in Hospital: A Descriptive Analysis | Health care providers | Clinical research |
Massive hemorrhage protocol survey: Marked variability and absent in one-third of hospitals in Ontario, Canada | Chin V, Cope S, Yeh CH, Thompson T, Nascimento B, Pavenski K, Callum J | 2019 | Injury | View Massive hemorrhage protocol survey: Marked variability and absent in one-third of hospitals in Ontario, Canada | Health care providers | Clinical research |
Blood coagulation dissected | Pryzdial ELG, Lee FMH, Lin BH, Carter RLR, Tegegn TZ, Belletrutti MJ | 2018 | Transfus Apher Sci | View Blood coagulation dissected | Health care providers | Other |
Serologic assessments in acute transfusion reactions: practices and yields | Cohen R, Lima A, Escorcia A, Tasmin F, Lin Y, Lieberman L, Pendergrast J, Callum J, Cserti-Gazdewich C | 2019 | Vox Sang | View Serologic assessments in acute transfusion reactions: practices and yields | Health care providers | Clinical research |
An open-source python library for detection of known and novel Kell, Duffy and Kidd variants from exome sequencing | Montemayor C, Simone A, Long J, Montemayor O, Delvadia B, Rivera R, Lewis KL, Shahsavari S, Gandla D, Dura K, Krishnan US, Wendzel NC, Elavia N, Grissom S, Karagianni P, Bueno M, Loy D, Cacanindin R, McLaughlin S, Tynuv M, Brunker PAR, Roback J, Adams S, Smith H, Biesecker L, Klein HG | 2021 | Vox Sang | View An open-source python library for detection of known and novel Kell, Duffy and Kidd variants from exome sequencing | Health care providers | New or improved product or process |
Research Unit: Protecting patients with sickle cell disease from alloimmunization risk: benefits of genotyping | Shih AW | 2020 | Blood.ca website | View Research Unit: Protecting patients with sickle cell disease from alloimmunization risk: benefits of genotyping | Health care providers | Clinical research |
Transfusion-related Epstein-Barr virus (EBV) infection: A multicenter prospective cohort study among pediatric recipients of hematopoietic stem cell transplants (TREASuRE study) | Enok Bonong PR, Buteau C, Delage G, Tanner JE, Lacroix J, Duval M, Laporte L, Tucci M, Robitaille N, Spinella PC, Cuvelier G, Vercauteren S, Lewis V, Fearon M, Drews SJ, Alfieri C, Trottier H | 2021 | Transfusion | View Transfusion-related Epstein-Barr virus (EBV) infection: A multicenter prospective cohort study among pediatric recipients of hematopoietic stem cell transplants (TREASuRE study) | Health care providers | Clinical research |
Circular of information for the use of human blood components: Plasma Components | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Plasma Components | Health care providers | Benchmarking and standard setting |
Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria | Gabe C, Sirotich E, Li N, Ivetic N, Nazy I, Smith J, Kelton JG, Arnold DM | 2021 | Br J Haematol | View Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria | Health care providers | Clinical research |
The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A | Ay C, Kovacevic KD, Kraemmer D, Schoergenhofer C, Gelbenegger G, Firbas C, Quehenberger P, Jilma-Stohlawetz P, Gilbert JC, Zhu S, Beliveau M, Koenig F, Iorio A, Jilma B, Derhaschnig U, Pabinger I | 2023 | Blood | View The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A | Health care providers | Clinical research |
2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy | Zhang X, Chen F, Chen X, Cheng Y, Fang M, Feng J, Fu H, Gao H, Han Y, He A, Hou M, Hu Y, Huang R, Huang W, Jing Z, Kong P, Liang A, Liang M, Liu D, Liu J, Liu L, Liu X, Ma L, Mei H, Ni H, Niu T, Peng J, Qiao J, Ren J, Song Y, Tang LV, Tong T, Wang S, Wang X, Wang Z, Wei H, Wu D, Wu G, Xu C, Xu X, Xu Y, Yang L, Yang R, Yang T, Yin C, Yu L, Zhang G, Zhang L, Zhang L, Zhang X, Zhao W, Zhao Y, Zhou D, Zhou H, Zhou Z, Zhu T, Wang J, Huang X | 2022 | Chin Med J (Engl) | View 2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy | Health care providers | Clinical research |
A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab | Clark WF, Rock G, Barth D, Arnold DM, Webert KE, Yenson PR, Kelton JG, Li L, Foley SR, members of the Canadian Apheresis G | 2015 | Br J Haematol | View A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab | Health care providers | Clinical research |
Blood and clots series: My patient has a pulmonary embolism. Should I screen them for cancer? | Tseng E | 2018 | CanadiEM website | View Blood and clots series: My patient has a pulmonary embolism. Should I screen them for cancer? | Health care providers | Benchmarking and standard setting |
Comorbidities in persons with haemophilia aged 60 years or more compared with age-matched people from the general population | Marchesini E, Oliovecchio E, Coppola A, Santagostino E, Radossi P, Castaman G, Valdre L, Santoro C, Tagliaferri A, Ettorre C, Zanon E, Barillari G, Cantori I, Caimi TM, Sottilotta G, Iorio A, Mannucci PM | 2018 | Haemophilia | View Comorbidities in persons with haemophilia aged 60 years or more compared with age-matched people from the general population | Health care providers | Clinical research |
Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia | Zeller MP, Heddle NM, Kelton JG, Hamilton K, Wang G, Sholapur N, Carruthers J, Hsia C, Blais N, Toltl L, Hamm C, Pearson M-A, Arnold DM | 2015 | Transfusion | View Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia | Health care providers | Clinical research |
Épreuves prétransfusionnelles | Lane D | 2017 | Guide de la pratique transfusionnelle | View Épreuves prétransfusionnelles | Health care providers | Benchmarking and standard setting |
External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR) | Mahan CE, Liu Y, Turpie AG, Vu JT, Heddle N, Cook RJ, Dairkee U, Spyropoulos AC | 2014 | Thromb Haemost | View External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR) | Health care providers | Clinical research |
Phenotype matching for sickle cell patients: a review and recommendations for transfusion practice | Skeate R, Goldman M | 2014 | Blood.ca website | View Phenotype matching for sickle cell patients: a review and recommendations for transfusion practice | Health care providers | Other |
Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies | Xu XR, Carrim N, Neves MAD, McKeown T, Stratton TW, Coelho RMP, Lei X, Chen P, Xu J, Dai X, Li BX, Ni H | 2016 | Thromb J | View Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies | Health care providers | Clinical research |
Scanning the future of transfusion medicine | Devine D, Dzik WH, Szczepiorkowski ZM | 2013 | Practical Transfusion Medicine, 4th edition | View Scanning the future of transfusion medicine | Health care providers | Other |
The Massive Online Needs Assessment (MONA) to inform the development of an emergency haematology educational blog series | Chan TM, Jo D, Shih AW, Bhagirath VC, Castellucci LA, Yeh C, Thoma B, Tseng EK, de Wit K | 2018 | Perspect Med Educ | View The Massive Online Needs Assessment (MONA) to inform the development of an emergency haematology educational blog series | Health care providers | Education research |
Transfusion-related alloimmunization in children: epidemiology and effects of chemotherapy | Solh Z, Athale U, Arnold DM, Cook RJ, Foley R, Heddle NM | 2016 | Vox Sang | View Transfusion-related alloimmunization in children: epidemiology and effects of chemotherapy | Health care providers | Clinical research |
Importance du fer chez les donneurs de sang total : la perspective canadienne | Pambrun C, Goldman M | 2018 | Blood.ca website | View Importance du fer chez les donneurs de sang total : la perspective canadienne | Health care providers | Other |
Neutropenia and monocytopenia in recurrent anaphylactoid reactions after red blood cell transfusions in a woman with immunoglobulin A (IgA) deficiency and anti-IgA | Warkentin TE, Morin P-A, Heddle NM | 2018 | Transfusion | View Neutropenia and monocytopenia in recurrent anaphylactoid reactions after red blood cell transfusions in a woman with immunoglobulin A (IgA) deficiency and anti-IgA | Health care providers | Clinical research |
Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ?possible cohort effect following the 2009 influenza pandemic | Skowronski DM, Leir S, De Serres G, Murti M, Dickinson JA, Winter A-L, Olsha R, Croxen MA, Drews SJ, Charest H, Martineau C, Sabaiduc S, Bastien N, Li Y, Petric M, Jassem A, Krajden M, Gubbay JB | 2019 | Euro Surveill | View Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ?possible cohort effect following the 2009 influenza pandemic | Health care providers | Clinical research |
Système Kell : l’anticorps anti-Jsa | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Kell : l’anticorps anti-Jsa | Health care providers | Benchmarking and standard setting |
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 | Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, Davila J, DeSancho MT, Diuguid D, Griffin DO, Kahn SR, Klok FA, Lee AI, Neumann I, Pai A, Pai M, Righini M, Sanfilippo KM, Siegal D, Skara M, Touri K, E AA, Bou Akl I, Boulos M, Brignardello-Petersen R, Charide R, Chan M, Dearness K, Darzi AJ, Kolb P, Colunga-Lozano LE, Mansour R, Morgano GP, Morsi RZ, Noori A, Piggott T, Qiu Y, Roldan Y, Schünemann F, Stevens A, Solo K, Ventresca M, Wiercioch W, Mustafa RA, Schünemann HJ | 2021 | Blood Adv | View American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 | Health care providers | Benchmarking and standard setting |
Circulaire d'information utilisation de composants sanguins humains: Culot globulaire partiellement déleucocyté (PD) | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
Exploring the frontiers of IVIG-associated hemolysis | Pendergrast J, Branch D | 2020 | Blood.ca website | View Exploring the frontiers of IVIG-associated hemolysis | Health care providers | Benchmarking and standard setting |
A user guide to the American Society of Hematology clinical practice guidelines | Izcovich A, Cuker A, Kunkle R, Neumann I, Panepinto J, Pai M, Seftel M, Cheung MC, Lottenberg R, Byrne M, Plovnick R, Terrell D, Holter-Chakrabarty JL, Djulbegovic B, Hicks LK, Wiercioch W, Nieuwlaat R, Schünemann HJ | 2020 | Blood Adv | View A user guide to the American Society of Hematology clinical practice guidelines | Health care providers | Benchmarking and standard setting |
Acute thrombocytopenia suggesting thrombotic microangiopathy | Venier LM, Patriquin CJ, Warkentin TE | 2022 | Am J Hematol | View Acute thrombocytopenia suggesting thrombotic microangiopathy | Health care providers | Clinical research |